1. Li, Yunzheng, Li, Binghua, Xu, Yanchao, Sun, Beicheng, Yu, Decai. . GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors. In Cancer research, 82, 3223-3235. doi:10.1158/0008-5472.CAN-22-0042. https://pubmed.ncbi.nlm.nih.gov/35895805/
2. Dong, Weilai, Wong, Karen H Y, Liu, Youbin, Lifton, Richard P, Pullinger, Clive R. 2022. Whole-exome sequencing reveals damaging gene variants associated with hypoalphalipoproteinemia. In Journal of lipid research, 63, 100209. doi:10.1016/j.jlr.2022.100209. https://pubmed.ncbi.nlm.nih.gov/35460704/
3. Prystupa, Tomasz Karol, Sagan, Dariusz, Kocki, Janusz, Szymanowski, Rafał, Bogucki, Jacek. 2023. Surgical resection of lung cancer inhibits mRNA expression of GOT2 gene encoding kynurenine aminotransferase in leukocytes. In Annals of agricultural and environmental medicine : AAEM, 30, 755-762. doi:10.26444/aaem/176813. https://pubmed.ncbi.nlm.nih.gov/38153082/
4. Buffet, Alexandre, Burnichon, Nelly, Favier, Judith, Gimenez-Roqueplo, Anne-Paule. 2020. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. In Best practice & research. Clinical endocrinology & metabolism, 34, 101416. doi:10.1016/j.beem.2020.101416. https://pubmed.ncbi.nlm.nih.gov/32295730/
5. Stegen, Steve, Rinaldi, Gianmarco, Loopmans, Shauni, Carmeliet, Peter, Carmeliet, Geert. 2020. Glutamine Metabolism Controls Chondrocyte Identity and Function. In Developmental cell, 53, 530-544.e8. doi:10.1016/j.devcel.2020.05.001. https://pubmed.ncbi.nlm.nih.gov/32470321/
6. Jiang, Haiyue, Zhang, Xiaoyue, Shen, Jiayang, Zhuang, Xun, Lian, Yulong. 2019. Association between CYP2E1 and GOT2 gene polymorphisms and susceptibility and low-dose N,N-dimethylformamide occupational exposure-induced liver injury. In International archives of occupational and environmental health, 92, 967-975. doi:10.1007/s00420-019-01436-1. https://pubmed.ncbi.nlm.nih.gov/30993423/
7. Ru, Bin, Hu, Jiaqi, Zhang, Nannan, Wan, Quan. 2023. A novel metabolism-related gene signature in patients with hepatocellular carcinoma. In PeerJ, 11, e16335. doi:10.7717/peerj.16335. https://pubmed.ncbi.nlm.nih.gov/38025761/
8. Zhang, Jing-Nan, Zhang, Ze, Huang, Zhen-Lin, Wang, Zheng-Tao, Ji, Li-Li. 2024. Isotoosendanin inhibits triple-negative breast cancer metastasis by reducing mitochondrial fission and lamellipodia formation regulated by the Smad2/3-GOT2-MYH9 signaling axis. In Acta pharmacologica Sinica, 45, 2672-2683. doi:10.1038/s41401-024-01335-3. https://pubmed.ncbi.nlm.nih.gov/39009651/
9. Liang, Qiuli, Liu, Shun, Yin, Fuqiang, Zhang, Di, Zeng, Xiaoyun. 2023. Low expression of GOT2 promotes tumor progress and predicts poor prognosis in hepatocellular carcinoma. In Biomarkers in medicine, 17, 755-765. doi:10.2217/bmm-2023-0236. https://pubmed.ncbi.nlm.nih.gov/38095985/
智鼠故事 
